ARCHIVES

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

This article is from The Cancer Letter archive.

Vol. 01 No. 09 | April 5, 1974

Download PDF Visit The Full Archive

Related Articles

New Abiraterone Acetate Results Show Greater Benefit Than Before

June 24, 2011

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

BCTF July, Sept. Meetings To Develop New Research Ideas

December 3, 1976

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

Study: Keytruda Improves PFS In Ipilimumab-Refactory Disease

November 28, 2014

Guidelines Published On Lung Cancer Treatment

February 28, 2003